E-therapuetics-logo
  • About us
    • Our approach
    • Our leadership
  • Our science
    • HepNet™ Computational Platform
    • GalOmic™ RNAi Platform
    • Therapeutic pipeline
    • Scientific publications
  • Partnering
  • Investors
    • Interim and annual reports
    • Regulatory announcements
      • RNS alerts signup
    • Share price tools
    • Shareholder centre
    • AIM Rule 26
    • Corporate governance
  • News and media
    • Press releases
    • Presentations and videos
  • Careers
  • Contact
    • Our approach

      Our approach

    • Our leadership

      Our leadership

    About us

    About us

    • HepNet™ Computational Platform

      HepNet™ Computational Platform

    • GalOmic™ RNAi Platform

      GalOmic™ RNAi Platform

    • Therapeutic pipeline

      Therapeutic pipeline

    • Scientific publications

      Scientific publications

    Our science

    Our science

  • Partnering

    Partnering

    • Interim and annual reports

      Interim and annual reports

      • RNS alerts signup

        RNS alerts signup

      Regulatory announcements

      Regulatory announcements

    • Share price tools

      Share price tools

    • Shareholder centre

      Shareholder centre

    • AIM Rule 26

      AIM Rule 26

    • Corporate governance

      Corporate governance

    Investors

    Investors

    • Press releases

      Press releases

    • Presentations and videos

      Presentations and videos

    News and media

    News and media

  • Careers

    Careers

  • Contact

    Contact

Globe placeholder banner

Search

  • Home
  • /
  • Search
  • Sitemap
  • Accessibility
  • Cookie declaration
  • Privacy policy
  • Terms

e-therapeutics plc
Floor 4, 4 Kingdom Street
Paddington Central
London
W2 6BD

e-therapeutics plc is incorporated in England and Wales.
Company number 04304473. e-therapeutics, 4B, Floor 4, 4 Kingdom Street, London, W2 6BD

Phone: +44 (0) 20 4551 8888

© 2023 e-therapeutics plc.